Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Atrofie van de cortex oorzaak van versnelde achteruitgang bij progressieve MS
sep 2019 | Multipele Sclerose